R&D News | pharmaphorum

News

J&J takes $2.58bn option to buy in vivo CAR-T firm Sail

Johnson & Johnson has bid for a slice of the in vivo CAR-T category, signing an alliance with Sail Bio that could evolve into a $2.58bn takeover.

News

Simple blood test could aid in global TB fight

A blood test for tuberculosis that can distinguish between dormant and active infections has shown promise in a clinical trial.

News

A man drunken on vodka lies in the grass

Altimmune alcohol use disorder drug hits the mark in phase 2

Altimmune's pemvidutide has been shown to reduce drinking in people with alcohol use disorder, adding to the evidence for GLP-1 drugs in this setting.

News

US judge says Novo Nordisk must face lawsuit over CagriSema

A US judge has ruled that Novo Nordisk must face a lawsuit claiming it defrauded investors with misleading statements about a pivotal CagriSema study.

News

GSK to quit Stevenage for new R&D site in Cambridge

In a major shake-up of its UK operations, GSK is building a brand new R&D centre in Cambridge and transfer operations there from its Stevenage campus.

News